Displaying 222 results out of a total of 3930 publications.
Sn-and Ge-triorganometallics exert different cytotoxicity and modulation of migration in triple-negative breast cancer cell line MDA-MB-231
Hunakovaa, L;Brtko, J;
Toxicology Letters, Toxicology Letters 279():16-21, 2017
View publication
Toxicology Letters, Toxicology Letters 279():16-21, 2017
The combination of metformin and valproic acid induces synergistic apoptosis in the presence of p53 and androgen signaling in prostate cancer
Tran, LNK;Kichenadasse, G;Butler, LM;Centenera, MM;Morel, KL;Ormsby, RJ;Michael, MZ;Lower, KM;Sykes, PJ;
Mol. Cancer Ther., Mol. Cancer Ther. ():, 2017
View publication
Mol. Cancer Ther., Mol. Cancer Ther. ():, 2017
A normalized drug response metric improves accuracy and consistency of drug sensitivity quantification in cell-based screening
Gupta, A;Gautam, P;Wennerberg, K;Aittokallio, T;
bioRxiv, bioRxiv ():, 2018
View publication
bioRxiv, bioRxiv ():, 2018
Single-domain antibody fusion proteins can target and shuttle functional proteins into macrophage mannose receptor expressing macrophages
De Vlaeminck, Y;Lecocq, Q;Giron, P;Heirman, C;Geeraerts, X;Bolli, E;Movahedi, K;Massa, S;Schoonooghe, S;Thielemans, K;Goyvaerts, C;Van Ginderachter, JA;Breckpot, K;
J Control Release, J Control Release 299():107-120, 2019
View publication
J Control Release, J Control Release 299():107-120, 2019
Low MSH2 protein levels identify muscle-invasive bladder cancer resistant to cisplatin
Goodspeed, A;Jean, A;Costello, J;
bioRxiv, bioRxiv ():, 2018
View publication
bioRxiv, bioRxiv ():, 2018
TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets
Decaesteker, B;Denecker, G;Van Neste, C;Dolman, EM;Van Loocke, W;Gartlgruber, M;Nunes, C;De Vloed, F;Depuydt, P;Verboom, K;Rombaut, D;Loontiens, S;De Wyn, J;Kholosy, WM;Koopmans, B;Essing, AHW;Herrmann, C;Dreidax, D;Durinck, K;Deforce, D;van Nieuwerburgh, F;Henssen, A;Versteeg, R;Boeva, V;Schleiermacher, G;van Nes, J;Mestdagh, P;Vanhauwaert, S;Schulte, JH;Westermann, F;Molenaar, JJ;De Preter, K;Speleman, F;
Nat Commun, Nat Commun 9(1):4866, 2018
View publication
Nat Commun, Nat Commun 9(1):4866, 2018
miR-29b Mediates the ChronicInflammatory Response in Radiotherapy-Induced Vascular Disease
Eken, S;Christersdottir, T;Winski, G;Sangsuwan, T;Jin, H;Chernogubova, E;Pirault, J;Sun, C;Simon, N;Winter, H;Backlund, A;Haghdoost, S;Hansson, G;Halle, M;Maegdefessel, L;
JACC: Basic to Translational Science, JACC: Basic to Translational Science 4(1):72-82, 2019
View publication
JACC: Basic to Translational Science, JACC: Basic to Translational Science 4(1):72-82, 2019
Resistance to Src inhibition alters the BRAF-mutant tumor secretome to promote an invasive phenotype and therapeutic escape through a FAK>p130Cas>c-Jun signaling axis
Kessler, BE;Mishall, KM;Kellett, MD;Clark, EG;Pugazhenthi, U;Pozdeyev, N;Kim, J;Tan, AC;Schweppe, RE;
Oncogene, Oncogene ():, 2018
View publication
Oncogene, Oncogene ():, 2018
MLKL Requires the Inositol Phosphate Code to Execute Necroptosis
Dovey, CM;Diep, J;Clarke, BP;Hale, AT;McNamara, DE;Guo, H;Brown, NW;Cao, JY;Grace, CR;Gough, PJ;Bertin, J;Dixon, SJ;Fiedler, D;Mocarski, ES;Kaiser, WJ;Moldoveanu, T;York, JD;Carette, JE;
Mol. Cell, Mol. Cell 70(5):936-948.e7, 2018
View publication
Mol. Cell, Mol. Cell 70(5):936-948.e7, 2018
Bax/Tubulin/Epithelial-Mesenchymal Pathways Determine the Efficacy of Silybin Analog HM015k in Colorectal Cancer Cell Growth and Metastasis
Amawi, H;Hussein, N;Ashby, C;Alnafisah, R;Sanglard, L;Manivannan, E;Karthikeyan, C;Trivedi, P;Eisenmann, K;Robey, R;Tiwari, A;
Front. Pharmacol., Front. Pharmacol. 9():, 2018
View publication
Front. Pharmacol., Front. Pharmacol. 9():, 2018